The prevalence of obesity has increased markedly in
|
|
- Pamela Cain
- 6 years ago
- Views:
Transcription
1 Brief Communication Use of Prescription Weight Loss Pills among U.S. Adults in Laura Kettel Khan, PhD; Mary K. Serdula, MD; Barbara A. Bowman, PhD; and David F. Williamson, PhD Background: Pharmacotherapy is recommended for the treatment of obese persons with a body mass index of 30 kg/m 2 or higher or a body mass index of at least 27 kg/m 2 plus an obesityrelated comorbid condition. Objective: To estimate the prevalence of use of prescription weight loss pills in the United States in Design: 1998 Behavioral Risk Factor Surveillance System, a nationally representative telephone survey. Setting: United States. Results: The 2-year prevalence of pill use was 2.5% (95% CI, 2.1% to 2.9%), or 4.6 million U.S. adults. Use was higher in women than in men (4.0% vs. 0.9%, respectively) and highest among Hispanic respondents (3.2%). Of pill users, 25% were not overweight (body mass index < 27 kg/m 2 ) before using pills. Conclusions: Nearly 5 million U.S. adults used prescription weight loss pills in However, one quarter of users were not overweight, suggesting that weight loss pills may be inappropriately used, especially among women, white persons, and Hispanic persons. Participants: adults 18 years of age and older. Measurements: Self-reported pill use for , body mass index (current and before pill use), age, sex, and race or ethnicity. Ann Intern Med. 2001;134: For author affiliations, current addresses, and contributions, see end of text. The prevalence of obesity has increased markedly in the United States (1), as has approval of weight loss drugs by the U.S. Food and Drug Administration (FDA). In 1959, the FDA approved phentermine, the first prescription appetite suppressant used as a singledrug, short-term treatment for obesity. The FDA approved fenfluramine in 1973 for single-drug, short-term use and dexfenfluramine in 1996 as a single-drug, prescription appetite suppressant for longer-term use in obese persons. From 1995 to mid-1997, fenfluramine or dexfenfluramine was widely used in combination with phentermine ( fen-phen ), often for periods longer than a few weeks (2). After numerous reports of cardiac valvulopathy in persons taking fenfluramine or dexfenfluramine (3), the FDA issued a public health advisory on 8 July 1997 (4) that led to the voluntary withdrawal of the drugs from the U.S. market on 15 September The U.S. Department of Health and Human Services estimated that between 1995 and 1997, 1.2 to 4.7 million persons in the United States used fenfluramine and dexfenfluramine (3). These figures, however, were not based on population surveys but were indirectly estimated from the number of prescriptions written, with assumptions about the median duration of treatment and mean length of a prescription (5). Thus, the extent to which the population has been exposed to prescription weight loss drugs remains uncertain. In addition, no data were available on the characteristics of persons using the drugs or on whether the drugs were used in accordance with the pharmacotherapy guidelines suggested by the FDA and the 1998 National Heart, Lung, and Blood Institute consensus statement (6, 7). The purpose of our study was to provide estimates of the prevalence of the use of prescription weight loss drugs by age, race or ethnicity, and sex by using data from a telephone survey in a sample of U.S. adults. METHODS We examined data from the 1998 Behavioral Risk Factor Surveillance System (BRFSS), a telephone survey of health practices of adults 18 years of age and older conducted by all U.S. state health departments. Each state, the District of Columbia, and Puerto Rico selected an independent probability sample of noninstitutionalized residents through random-digit dialing; the results were pooled for statistical analyses (Schulman J. Can BRFSS data be pooled for national estimates? Presented at the Sixteenth Annual Behavioral Risk Factor Surveillance System Conference, Minneapolis, Minnesota, 16 May 1999). In 1998, persons responded to the BRFSS. (A detailed description of survey methods and quality control indices has been published elsewhere February 2001 Annals of Internal Medicine Volume 134 Number 4
2 Use of Prescription Diet Pills in the United States Brief Communication [8].) In 1998, the median upper-bound response rate for individual states (completed interviews divided by completed, refused, and terminated interviews) was 73.4% (range, 45.4% to 95.4%). Body mass index (BMI) at the time of survey completion (current use) and before use of weight control pills was calculated as the self-reported weight in kilograms divided by height in meters squared and was categorized in five groups: normal weight ( 25 kg/m 2 ); preobesity (25 to 29 kg/m 2 ), obesity grade I (30 to 34 kg/m 2 ), obesity grade II (35 to 39 kg/m 2 ), and obesity grade III ( 40 kg/m 2 ) (7). According to guidelines of the FDA and National Heart, Lung, and Blood Institute, pharmacotherapy may be considered for persons who are clinically obese (body mass index 30 kg/m 2 ) or have a body mass index between 27 and 30 kg/m 2 plus an obesity-related comorbid condition (for example, hyperlipidemia, hypertension, diabetes, or cardiovascular disease) (6, 7). Because the BRFSS survey did not collect complete information on comorbid conditions, we conservatively defined inappropriate pill use as reported use of weight loss pills in a person with a body mass index less than 27 kg/m 2 before pill use. Of the respondents, we excluded those who did not report on pill use (1561 persons), weight before pill use (487 persons), current weight (5229 persons), height (1369 persons), pregnancy status (1780 persons), or sociodemographic characteristics or weight loss behavior (964 persons). We also excluded 88 respondents because the reported weight, height, or body mass index was outside the sex-specific reference values from the Third National Health and Nutrition Examination Survey, (9). After exclusions, our study sample consisted of respondents. To perform statistical analyses, we used SUDAAN software (Research Triangle Institute, Research Triangle Park, North Carolina), which could accommodate our complex sampling design (10). Survey weights were used to produce U.S. population estimates. RESULTS In , an estimated 2.5% (95% CI, 2.3% to 2.7%) of U.S. adults used prescription weight loss pills (Table 1). The 2-year prevalence was four times higher among women (4.0%) than men (0.9%) and was one third higher among Hispanic respondents (3.2%) than non-hispanic white (2.4%) or non-hispanic black (2.4%) respondents. Among men, pill use was highest in respondents 35 to 64 years of age, and among women, pill use was highest in those aged 25 to 44 years. Use of prescription weight loss pills increased with current body mass index (Table 1). Among women, the 2-year prevalence of pill use was lowest (1.5% [95% CI, 1.3% to 1.7%]) in those with a current body mass index less than 25 kg/m 2 but was substantially higher (17.7% [CI, 15.2% to 20.2%]) in those with a current body mass index of 40 kg/m 2 or greater. A similar relationship between pill use and current body mass index was observed among men but with consistently lower values (range, 0.2% to 9.1%). The sex-specific pattern of pill use for current body mass index was similar for all racial and ethnic groups (Table 1). Overall, prescription weight loss pills were used by 3.1% (CI, 2.5% to 3.7%) of obese men (body mass index 30 kg/m 2 ) and 10.2% (CI, 9.4% to 11.0%) of obese women. In an analysis restricted to persons who reported use of prescription weight loss pills (n 3822), we found that 56.1% (CI, 53.5% to 58.7%) of this group were obese before using these pills (Table 2). However, 25.3% (CI, 22.9% to 27.7%) were below the minimum recommended body mass index of 27 kg/m 2. Among persons with a body mass index less than 27 kg/m 2, pill use was twice as likely among women as men (27.9% [CI, 25.1% to 30.7%] vs. 13.2% [CI, 11.2% to 15.2%]) and almost twice as likely among non-hispanic white and Hispanic respondents (26.1% [CI, 24.7% to 27.5%] vs. 26.4% [CI, 22.9% to 29.9%]) as non-hispanic black respondents (15.0% [CI, 12.2% to 17.8%]). At the time of the survey, 0.5% ([CI, 0.48% to 0.52%]) of respondents were currently using prescription weight loss pills. Paralleling the 2-year prevalence of pill use, the rate for current reported use in women (0.8% [CI, 0.6% to 1.00%]) was fourfold that of men (0.2% [CI, 0.18% to 0.22%]). Except for a peak in current use in October (1.0% [CI, 0.96% to 1.04%]), little seasonal or monthly variation was seen in pill use during 1998 (range, 0.4% to 1.0%). DISCUSSION From this population-based study, we estimate that 4.6 million U.S. adults used prescription pills for weight loss in Women were four times as likely as 20 February 2001 Annals of Internal Medicine Volume 134 Number 4 283
3 Brief Communication Use of Prescription Diet Pills in the United States men to report pill use. Reported use was similar in white and black respondents but was about one third higher among Hispanic respondents than in white and black respondents. Although Hispanic persons have shown a greater inclination toward antibiotic use compared with non-hispanic persons (11), without more information we cannot speculate on reasons for the higher use of weight loss pills among Hispanic respondents in the current study. Pill use increased with increasing body mass index and was three times higher among obese women than obese men. Among severely obese respondents (body mass index 40 kg/m 2 ), the rate of pill use was nearly twice as high in women as men. Reported use of prescription weight loss pills was also substantial among adults who were not obese. In our analysis, we used a conservative definition of appropriate pill use a body mass index of 27 kg/m 2 or greater. We estimate that one eighth of men and more than one fourth of women who used prescription weight loss pills in had a pre-pill body mass index less than the minimum body mass index of 27 kg/m 2 suggested in the FDA and National Heart, Lung, and Blood Institute guidelines. Thus, we estimate that at least 1.2 million adults may have inappropriately used pills in that period. Inappropriate pill use was substantially higher among non- Hispanic white and Hispanic respondents than non- Hispanic black respondents. Our analysis is limited by the lack of information on the specific prescription drugs used, duration of drug use, dosage, and weight loss during use of the drug. Because the Behavioral Risk Factor Surveillance System did not ask about drugs used concurrently with prescription weight loss pills, no conclusions can be made about Table 1. Two-Year Prevalence of Use of Prescription Weight Loss Pills among U.S. Adults* Characteristic Survey Respondents Non-Hispanic White (n ) Non-Hispanic Black (n ) Hispanic (n ) Other (n 5075) Total (95% CI) (n ) 4OOOOOOOOOOOOOOOOOOOOOOOOOO % OOOOOOOOOOOOOOOOOOOOOOOOOO3 Male ( ) Female ( ) Total ( ) Age Male y ( ) y ( ) y ( ) y ( ) y ( ) 65 y ( ) Female y ( ) y ( ) y ( ) y ( ) y ( ) 65 y ( ) Current body mass index Male 25 kg/m ( ) kg/m ( ) kg/m ( ) kg/m ( ) 40 kg/m ( ) Female 25 kg/m ( ) kg/m ( ) kg/m ( ) kg/m ( ) 40 kg/m ( ) * Adults refers to respondents 18 years of age and older February 2001 Annals of Internal Medicine Volume 134 Number 4
4 Use of Prescription Diet Pills in the United States Brief Communication Table 2. U.S. Adults Who Used Prescription Weight Loss Pills, according to Body Mass Index before Pill Use* Body Mass Index Survey Respondents Non-Hispanic White (n 3058) Non-Hispanic Black (n 305) Hispanic (n 367) Other (n 92) Total (95% CI) (n 3822) 4OOOOOOOOOOOOOOOOOOOOOOOOOOO % OOOOOOOOOOOOOOOOOOOOOOOOOOO3 27 kg/m 2 Male ( ) Female ( ) Total ( ) kg/m 2 Male ( ) Female ( ) Total ( ) 30 kg/m 2 Male ( ) Female ( ) Total ( ) 40 kg/m 2 Male ( ) Female ( ) Total ( ) * Adults refers to respondents 18 years of age and older. the potential for adverse effects or drug interactions. Self-reported weight may also be a concern because many people, especially those who are relatively heavy, may under-report their weight (12, 13). Although the number of pills prescribed may have decreased immediately before the survey, no data are available for prevalence by month in However, the prevalence of current use throughout 1998 did not vary by month or season, except in October 1998, which was nearly 1 year after the public advisory on fenfluramine and dexfenfluramine. Our data indicate that one quarter of U.S. adults who use prescription weight loss pills were not overweight when the pills were prescribed. Other data suggest that more than one third of overweight persons do not meet recommendations for physical activity and dietary practices (12). Furthermore, fewer than half of physicians counsel overweight persons about weight control (14). Taken together, these findings suggest that many overweight persons lack the knowledge or ability to implement lifestyle changes effectively. Patients might be better served if more of them were counseled about long-term weight control and if their physicians adhered more closely to recommendations for initiation of pharmacotherapy. Furthermore, given the increasing prevalence of obesity in the United States, as well as the availability of new prescription weight loss drugs, future investigations of weight-control behaviors and prescription practices are needed. From the Centers for Disease Control and Prevention, Atlanta, Georgia. Requests for Single Reprints: Laura Kettel Khan, PhD, Division of Nutrition and Physical Activity, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, Mailstop K26, Atlanta, GA 30341; , LDK7@cdc.gov. Current Author Addresses: Drs. Khan, Serdula, and Bowman: Division of Nutrition and Physical Activity, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, Mailstop K26, Atlanta, GA Dr. Williamson: Division of Diabetes Translation, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, Mailstop K26, Atlanta, GA Author Contributions: Conception and design: L.K. Khan, M.K. Serdula, B.A. Bowman, D.F. Williamson. Analysis and interpretation of the data: L.K. Khan, M.K. Serdula, B.A. Bowman, D.F. Williamson. Drafting of the article: L.K. Khan, M.K. Serdula, B.A. Bowman, D.F. Williamson. Critical revision of the article for important intellectual content: L.K. Khan, M.K. Serdula, B.A. Bowman, D.F. Williamson. Final approval of the article: L.K. Khan, M.K. Serdula, B.A. Bowman, D.F. Williamson. Provision of study materials or patients: L.K. Khan, M.K. Serdula, B.A. Bowman, D.F. Williamson. Statistical expertise: L.K. Khan February 2001 Annals of Internal Medicine Volume 134 Number 4 285
5 Brief Communication Use of Prescription Diet Pills in the United States References 1. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, Int J Obes Relat Metab Disord. 1998;22: [PMID: ] 2. Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, et al. Valvular heart disease associated with fenfluraminephentermine. N Engl J Med. 1997;337: [PMID: ] 3. Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: U.S. Department of Health and Human Services interim public health recommendations, November MMWR Morb Mortal Wkly Rep. 1997;46: [PMID: ] 4. Lumpkin MM. FDA health advisory. FDA Bull. 1997;27:2. 5. IMS America Ltd. National Prescription Audit. Basic Data Report. Ambler, PA: IMS America Ltd; Physicians Desk Reference. 58th ed. Oradell, NJ: Medical Economics; National Heart, Lung, and Blood Institute. National Institute of Diabetes and Digestive and Kidney Diseases (U.S.). Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Bethesda, MD: National Heart, Lung, and Blood Institute in cooperation with the National Institute of Diabetes and Digestive and Kidney Diseases; Nelson DE, Holtzman D, Waller M, Leutzinger CL, Condon K. Objectives and design of the Behavioral Risk Factor Surveillance System. Proceedings of the Section on Survey Methods, American Statistical Association National Meeting: Dallas, TX; National Center for Health Statistics (U.S.). Third National Health and Nutrition Examination Survey, NHANES III Reference Manuals and Reports [computer file]. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Health Statistics. Hyattsville, MD: Centers for Disease Control and Prevention; Shah BV, Barnwell BG, Bieler GS. SUDAAN User s Manual. Release 7.5. Research Triangle Park, NC: Research Triangle Institute; McKee MD, Mills L, Mainous AG 3rd. Antibiotic use for the treatment of upper respiratory infections in a diverse community. J Fam Pract. 1999;48: [PMID: ] 12. Serdula MK, Mokdad AH, Williamson DF, Galuska DA, Mendlein JM, Heath GW. Prevalence of attempting weight loss and strategies for controlling weight. JAMA. 1999;282: [PMID: ] 13. Rowland ML. Self-reported weight and height. Am J Clin Nutr. 1990;52: [PMID: ] 14. Galuska DA, Will JC, Serdula MK, Ford ES. Are health care professionals advising obese patients to lose weight? JAMA. 1999;282: [PMID: ] February 2001 Annals of Internal Medicine Volume 134 Number 4
Judy Kruger, PhD, MS, Deborah A. Galuska, PhD, MPH, Mary K. Serdula, MD, MPH, Deborah A. Jones, PhD
Attempting to Lose Weight Specific Practices Among U.S. Adults Judy Kruger, PhD, MS, Deborah A. Galuska, PhD, MPH, Mary K. Serdula, MD, MPH, Deborah A. Jones, PhD Background: Methods: Results: Conclusions:
More informationProjection of Diabetes Burden Through 2050
Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Projection of Diabetes Burden Through 2050 Impact of changing demography and disease prevalence in the U.S. JAMES P. BOYLE,
More informationSUCCESSFUL WEIGHT LOSS AND
ORIGINAL CONTRIBUTION Use of Nonprescription Weight Loss Products Results From a Multistate Survey Heidi Michels Blanck, PhD Laura Kettel Khan, PhD Mary K. Serdula, MD SUCCESSFUL WEIGHT LOSS AND healthy
More informationTHE PREVALENCE OF OVERweight
ORIGINAL CONTRIBUTION Prevalence and Trends in Overweight Among US Children and Adolescents, 1999-2000 Cynthia L. Ogden, PhD Katherine M. Flegal, PhD Margaret D. Carroll, MS Clifford L. Johnson, MSPH THE
More informationDATA FROM THE THIRD NAtional
ORIGINAL CONTRIBUTION Prevalence and Trends in Obesity Among US Adults, 1999-2000 Katherine M. Flegal, PhD Margaret D. Carroll, MS Cynthia L. Ogden, PhD Clifford L. Johnson, MSPH DATA FROM THE THIRD NAtional
More informationRecommended Levels of Physical Activity and Health- Related Quality of Life Among Overweight and Obese Adults in the United States, 2005
Journal of Physical Activity and Health, 2009, 6, 403-411 2009 Human Kinetics, Inc. Recommended Levels of Physical Activity and Health- Related Quality of Life Among Overweight and Obese Adults in the
More informationAssociations of Trying to Lose Weight, Weight Control Behaviors, and Current Cigarette Use Among US High School Students
R ESEARCHA RTICLE Associations of Trying to Lose Weight, Weight Control Behaviors, and Current Cigarette Use Among US High School Students JONETTA L. JOHNSON,MPH a DANICE K. EATON,MPH,PhD b LINDA L. PEDERSON,PhD
More informationHealth Concern. Obesity Guilford County Department of Public Health Community Health Assessment
2012-2013 Guilford County Department of Public Health Community Health Assessment 10 Health Concern The leading causes of death in Guilford County are chronic degenerative diseases, especially cancer and
More informationObesity Trends:
Obesity Trends: 1985-2014 Compiled by the Centers for Disease Control and Prevention Retrieved from http://www.cdc.gov/obesity/data/prevalencemaps.html Organized into two groupings due to methodological
More informationIn a recent meta-analysis of randomized clinical trials, Miller
Brief Communication: The Prevalence of High Intake of Vitamin E from the Use of Supplements among U.S. Adults Earl S. Ford, MD, MPH; Umed A. Ajani, MBBS, MPH; and Ali H. Mokdad, PhD Article Background:
More informationRacial and Ethnic Differences in Secular Trends for Childhood BMI, Weight, and Height
Risk Factors and Chronic Disease Racial and Ethnic Differences in Secular Trends for Childhood BMI, Weight, and Height David S. Freedman,* Laura Kettel Khan,* Mary K. Serdula,* Cynthia L. Ogden, and William
More informationConsumers of Dietary Supplements: Gender and Immigrant Status Differences Among College Students
ISPUB.COM The Internet Journal of Alternative Medicine Volume 3 Number 1 Consumers of Dietary Supplements: Gender and Immigrant Status Differences Among College Students J Fogel, N Kholodenko Citation
More informationweight perception, weight reduction, telephone interview 183 (16.8 ) 411 (37.7 ) (40.9 ) (31.8 ) (30.4 ) 8.5 ( 2001; 11: )
1 2 2 2 2 2 weight perception, weight reduction, telephone interview 90 12 22 23 20 49 1091 ( 78.3 ) 554 (50.8 ) 537 (49.2 ) 1091 183 (16.8 ) 50 133 101 (9.3 ) 31 70 411 (37.7 ) 180 231 (40.9 ) (31.8 )
More informationWhy Do We Treat Obesity? Epidemiology
Why Do We Treat Obesity? Epidemiology Epidemiology of Obesity U.S. Epidemic 2 More than Two Thirds of US Adults Are Overweight or Obese 87.5 NHANES Data US Adults Age 2 Years (Crude Estimate) Population
More informationThis slide set provides an overview of the impact of type 1 and type 2 diabetes mellitus in the United States, focusing on epidemiology, costs both
This slide set provides an overview of the impact of type 1 and type 2 diabetes mellitus in the United States, focusing on epidemiology, costs both direct and indirect and the projected burden of diabetes,
More informationIncreases in morbid obesity in the USA:
Public Health (2007) 121, 492 496 www.elsevierhealth.com/journals/pubh Original Research Increases in morbid obesity in the USA: 2000 2005 RAND, 1776 Main Street, Santa Monica, CA 90401, USA Received 11
More informationAPPETITE-SUPPRESSANT DRUGS AND THE RISK OF CARDIAC-VALVE REGURGITATION
APPETITE-SUPPRESSANT DRUGS AND THE RISK OF CARDIAC-VALVE REGURGITATION A POPULATION-BASED STUDY OF APPETITE-SUPPRESSANT DRUGS AND THE RISK OF CARDIAC-VALVE REGURGITATION HERSHEL JICK, M.D., CATHERINE VASILAKIS,
More informationLooking Toward State Health Assessment.
CONNECTICUT DEPARTMENT OF PUBLIC HEALTH Policy, Planning and Analysis. Looking Toward 2000 - State Health Assessment. Table of Contents Glossary Maps Appendices Publications Public Health Code PP&A Main
More informationTrends in Health Disparities in North Carolina by Region 1
Trends in Health Disparities in North Carolina by Region 1 July 11 Satomi Imai, Ph. D. Center for Health Services Research and Development East Carolina University Ten-Year Trends in Regional Disparities
More informationFDA approves Belviq to treat some overweight or obese adults
FDA approves Belviq to treat some overweight or obese adults Silver Spring, MD, USA (June 27, 2012) - The U.S. Food and Drug Administration today approved Belviq (lorcaserin hydrochloride), as an addition
More informationProgress in the Control of Childhood Obesity
William H. Dietz, MD, PhD a, Christina D. Economos, PhD b Two recent reports from the Centers for Disease Control and Prevention and reports from a number of states and municipalities suggest that we are
More informationDISPROPORTIONATE IMPACT OF DIABETES IN A PUERTO RICAN COMMUNITY OF CHICAGO
Journal of Community Health, Vol. 31, No. 6, December 2006 (Ó 2006) DOI: 10.1007/s10900-006-9023-7 DISPROPORTIONATE IMPACT OF DIABETES IN A PUERTO RICAN COMMUNITY OF CHICAGO Steve Whitman, PhD; Abigail
More informationDefinitions. Obesity: Having a very high amount of body fat in relation to lean body mass, or Body Mass Index (BMI) of 30 or higher.
Obesity in America Definitions Obesity: Having a very high amount of body fat in relation to lean body mass, or Body Mass Index (BMI) of 30 or higher. Body Mass Index (BMI): A measure of an adult s weight
More informationPrevalence of Self-Reported Obesity Among U.S. Adults by State and Territory. Definitions Obesity: Body Mass Index (BMI) of 30 or higher.
Prevalence of Self-Reported Obesity Among U.S. Adults by State and Territory Definitions Obesity: Body Mass Index (BMI) of 30 or higher. Body Mass Index (BMI): A measure of an adult s weight in relation
More informationMagnesium intake and serum C-reactive protein levels in children
Magnesium Research 2007; 20 (1): 32-6 ORIGINAL ARTICLE Magnesium intake and serum C-reactive protein levels in children Dana E. King, Arch G. Mainous III, Mark E. Geesey, Tina Ellis Department of Family
More informationState-Level Estimates of Annual Medical Expenditures Attributable to Obesity*
State-Level Estimates of Annual Medical Expenditures Attributable to Obesity* Eric A. Finkelstein, Ian C. Fiebelkorn, and Guijing Wang Abstract FINKELSTEIN, ERIC A., IAN C. FIEBELKORN, AND GUIJING WANG.
More informationTrends in adult obesity
53 by Margot Shields and Michael Tjepkema Keywords: body mass index, body weight, income, smoking In recent years, the percentage of Canadian adults with excess weight has increased considerably, part
More informationPrevalence of Overweight Among Anchorage Children: A Study of Anchorage School District Data:
Department of Health and Social Services Division of Public Health Section of Epidemiology Joel Gilbertson, Commissioner Richard Mandsager, MD, Director Beth Funk, MD, MPH, Editor 36 C Street, Suite 54,
More informationDavid V. McQueen. BRFSS Surveillance General Atlanta - Rome 2006
David V. McQueen Associate Director for Global Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Atlanta BRFSS Surveillance General Atlanta - Rome 2006 Behavioral Risk
More informationClinical and Behavioral Characteristics of HIV-infected Young Adults in Care in the United States
Clinical and Behavioral Characteristics of HIV-infected Young Adults in Care in the United States Linda Beer, PhD, Christine L. Mattson, PhD, Joseph Prejean, PhD, and Luke Shouse, MD 10 th International
More informationARTICLE. Prevalence of Diabetes and Impaired Fasting Glucose Levels Among US Adolescents. National Health and Nutrition Examination Survey,
ARTICLE Prevalence of Diabetes and Impaired Fasting Glucose Levels Among US Adolescents National Health and Nutrition Examination Survey, 1999-2002 Glen E. Duncan, PhD, RCEPSM Objective: To determine the
More informationTrends in Overweight among
Trends in Overweight among US Adults from 1987 to 1993: A Multistate Telephone Survey Deborahl A. Galuska, PhD, MPH, Mart Serdula, MD, MPH, Elsie Pamulk, PhD, Palul Z. Siegel, MD, and Tim Bvers, MD, MPH
More informationMemphis and Shelby County Behavioral Risk Factors Survey, 2004
Memphis and Shelby County Behavioral Risk Factors Survey, 2004 Marion Hare 2, David R. Forde 1, James Bailey 2, Deborah Gibson 2, and See Trail Mackey 1 A joint project of the 1 University of Memphis Mid-South
More informationMyths, Heart Disease and the Latino Population. Maria T. Vivaldi MD MGH Women s Heart Health Program. Hispanics constitute 16.3 % of US population!
Myths, Heart Disease and the Latino Population Maria T. Vivaldi MD MGH Women s Heart Health Program Hispanics constitute 16.3 % of US population! 1 LEADING CAUSES OF DEATH IN LATINOS Heart disease is the
More informationORIGINAL INVESTIGATION
ORIGINAL INVESTIGATION The Influence of Physician Acknowledgment of Patients Weight Status on Patient Perceptions of Overweight and Obesity in the United States Robert E. Post, MD, MS; Arch G. Mainous
More informationAge 18 years and older BMI 18.5 and < 25 kg/m 2
Quality ID #128 (NQF 0421): Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan National Quality Strategy Domain: Community/Population Health 2018 OPTIONS F INDIVIDUAL MEASURES:
More informationACCULTURATION, WEIGHT, AND WEIGHT-RELATED BEHAVIORS
ACCULTURATION, WEIGHT, AND WEIGHT-RELATED BEHAVIORS AMONG MEXICAN AMERICANS IN THE UNITED STATES Objective: This analysis explores the association between acculturation and body weight, self-perceptions
More informationAge 18 years and older BMI 18.5 and < 25 kg/m 2
Quality ID #128 (NQF 0421): Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan National Quality Strategy Domain: Community/Population Health 2018 OPTIONS F INDIVIDUAL MEASURES:
More informationPolicy Brief: Weight Loss Success among Overweight and Obese Women of Mexican-origin
Policy Brief: Weight Loss Success among Overweight and Obese Women of Mexican-origin Living In Mexico and the United States Sylvia Guendelman, Miranda Ritterman-Weintraub, Martha Kaufer-Horwitz (J Immigrant
More informationEstimates of Influenza Vaccination Coverage among Adults United States, Flu Season
Estimates of Influenza Vaccination Coverage among Adults United States, 2017 18 Flu Season On This Page Summary Methods Results Discussion Figure 1 Figure 2 Figure 3 Figure 4 Table 1 Additional Estimates
More informationHypertension awareness, treatment, and control
O r i g i n a l P a p e r Prevalence of Self-Reported High Blood Pressure Awareness, Advice Received From Health Professionals, and Actions Taken to Reduce High Blood Pressure Among US Adults Healthstyles
More informationOVERALL TRENDS IN OBESITY
ORIGINAL CONTRIBUTION ONLINE FIRST Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010 Katherine M. Flegal, PhD Margaret D. Carroll, MSPH Brian K. Kit, MD
More informationACCEPTED. Clinical outcomes of young black men receiving HIV medical care in the United States,
JAIDS Journal of Acquired Immune Deficiency Syndromes Publish Ahead of Print DOI: 10.1097/QAI.0000000000001987 Downloaded from https://journals.lww.com/jaids by lbmeglfgh5gub5fwzkblaba4mgfz5lgruzvpamcudzs4y5bsvzvwi2twdy1ndisdaxua4n3o1uqh7xa/xhhvezjeefglm41mjiflm7fit6+pckgnwugngq0czm6tywuo9pzebxidnq0=
More informationObesity and Control. Body Mass Index (BMI) and Sedentary Time in Adults
Obesity and Control Received: May 14, 2015 Accepted: Jun 15, 2015 Open Access Published: Jun 18, 2015 http://dx.doi.org/10.14437/2378-7805-2-106 Research Peter D Hart, Obes Control Open Access 2015, 2:1
More informationThe U.S. Obesity Epidemic: Causes, Consequences and Health Provider Response. Suzanne Bennett Johnson 2012 APA President
The U.S. Obesity Epidemic: Causes, Consequences and Health Provider Response Suzanne Bennett Johnson 2012 APA President sbjohnson@apa.org Presentation Overview Epidemiology of obesity Consequences of obesity
More informationDiabetes Care 31: , 2008
Clinical Care/Education/Nutrition/Psychosocial Research O R I G I N A L A R T I C L E Weight Loss Strategies Associated With BMI in Overweight Adults With Type 2 Diabetes at Entry Into the Look AHEAD (Action
More informationPrevalence of Obesity in Adult Population of Former College Rowers
Prevalence of Obesity in Adult Population of Former College Rowers John W. O Kane, MD, Carol C. Teitz, MD, Santana M. Fontana, MD, and Bonnie K. Lind, MS Background: The prevalence of adolescent and adult
More informationA: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups
A: Epidemiology update Evidence that LDL-C and CRP identify different high-risk groups Women (n = 27,939; mean age 54.7 years) who were free of symptomatic cardiovascular (CV) disease at baseline were
More informationGoal setting frequency and the use of behavioral strategies related to diet and physical activity
HEALTH EDUCATION RESEARCH Vol.22 no.4 2007 Pages 532 538 Advance Access publication 10 October 2006 Goal setting frequency and the use of behavioral strategies related to diet and physical activity Abstract
More informationAdult overweight and obesity
Facts on Adult overweight and obesity March 2017 in Durham Region Highlights In 2013/2014, 57 per cent of Durham Region adults 18 and older were overweight or obese. Rates for both Durham Region and Ontario
More informationChanges in Incidence of Diabetes in U.S. Adults,
Changes in Incidence of Diabetes in U.S. Adults, 1997 2003 Linda S. Geiss, MA, Liping Pan, MD, MPH, Betsy Cadwell, MSPH, Edward W. Gregg, PhD, Stephanie M. Benjamin, PhD, Michael M. Engelgau, MD, MPH Background:
More informationObjectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT
Diabetes- The Real Cost of Sugar By Ruth Nekonchuk RD CDE LMNT Objectives To explain diabetes To explain the risks of diabetes To enumerate the cost of diabetes to our country To enumerate the cost of
More informationPrevalence of Physical Activity in the United States: Behavioral Risk Factor Surveillance System, 2001
ORIGINAL RESEARCH Prevalence of Physical Activity in the United States: Behavioral Risk Factor Surveillance System, 2001 Caroline A. Macera, PhD, Sandra A. Ham, MS, Michelle M. Yore, MSPH, Deborah A. Jones,
More informationChronic kidney disease (CKD) has received
Participant Follow-up in the Kidney Early Evaluation Program (KEEP) After Initial Detection Allan J. Collins, MD, FACP, 1,2 Suying Li, PhD, 1 Shu-Cheng Chen, MS, 1 and Joseph A. Vassalotti, MD 3,4 Background:
More informationObesity in Cleveland Center for Health Promotion Research at Case Western Reserve University. Weight Classification of Clevelanders
Obesity in Cleveland 2005-2006 March 2008 Report Contents Weight Classification of Clevelanders Local, State and National Trends in the Prevalence of Obesity Obesity by Demographic Characteristics Nutrition,
More informationPreventive Medicine 55 (2012) Contents lists available at SciVerse ScienceDirect. Preventive Medicine
Preventive Medicine 55 (2012) 93 100 Contents lists available at SciVerse ScienceDirect Preventive Medicine journal homepage: www.elsevier.com/locate/ypmed In denial: Misperceptions of weight change among
More informationDiabetes Care Publish Ahead of Print, published online February 25, 2010
Diabetes Care Publish Ahead of Print, published online February 25, 2010 Undertreatment Of Mental Health Problems In Diabetes Undertreatment Of Mental Health Problems In Adults With Diagnosed Diabetes
More informationChapter 1: CKD in the General Population
Chapter 1: CKD in the General Population Overall prevalence of CKD (Stages 1-5) in the U.S. adult general population was 14.8% in 2011-2014. CKD Stage 3 is the most prevalent (NHANES: Figure 1.2 and Table
More informationWe used self-reported data from United Methodist
High Rates of Obesity and Chronic Disease among United Methodist Clergy Rae Jean Proeschold-Bell, Ph.D. Duke Global Health Institute Duke University Center for Health Policy Durham, N.C. rae.jean@duke.edu
More informationOverweight and obesity in the United States: prevalence and trends, 1960±1994
International Journal of Obesity (1998) 22, 39±47 ß 1998 Stockton Press All rights reserved 0307±0565/98 $12.00 : prevalence and trends, 1960±1994 KM Flegal, MD Carroll, RJ Kuczmarski and CL Johnson National
More informationManagement of Obesity. Objectives. Background Impact and scope of Obesity. Control of Energy Homeostasis Methods of treatment Medications.
Medical Management of Obesity Ben O Donnell, MD 1 Objectives Background Impact and scope of Obesity Control of Energy Homeostasis Methods of treatment Medications 2 O'Donnell 1 Impact of Obesity According
More informationNational Diabetes Fact Sheet, 2007
National Diabetes Fact Sheet, 2007 General Information What is diabetes? Diabetes is a group of diseases marked by high levels of blood glucose resulting from defects in insulin production, insulin action,
More informationPredictors of Perceived Risk of the Development of Diabetes
Predictors of Perceived Risk of the Development of Diabetes Joanne Gallivan, MS, RD, Clarice Brown, MS, Rachel Greenberg, MA, and Charles M. Clark, Jr., MD Adress correspondence to Clarice Brown, MS, Social
More informationCHILDHOOD OBESITY CONTINues
ORIGINAL CONTRIBUTION ONLINE FIRST Prevalence of Obesity and Trends in Body Mass Index Among US Children and Adolescents, 1999-2010 Cynthia L. Ogden, PhD, MRP Margaret D. Carroll, MSPH Brian K. Kit, MD,
More informationHigh Rates of Obesity and Chronic Disease Among United Methodist Clergy
High Rates of Obesity and Chronic Disease Among United Methodist Clergy Rae Jean Proeschold-Bell and Sara LeGrand Duke Global Health Institute Duke University Center for Health Policy and Inequalities
More informationIn the late 1970s, it became apparent that seasonality. Seasonal Variation in Adult Leisure-Time Physical Activity. Epidemiology
Epidemiology Seasonal Variation in Adult Leisure-Time Physical Activity JAMES M. PIVARNIK 1,2, MATHEW J. REEVES 3, and ANN P. RAFFERTY 4 Departments of 1 Kinesiology, 2 Physical Medicine & Rehabilitation,
More informationin Two South Carolina Communities
Self-Reported Frequency of Serum Cholesterol Testing, Awareness of Test Results, and Laboratory Cholesterol Values in Two South Carolina Communities GREGORY W. HEATH, DHSc, MPH ERKKI VARTIAINEN, MD,.PhD
More informationTrends in COPD (Chronic Bronchitis and Emphysema): Morbidity and Mortality. Please note, this report is designed for double-sided printing
Trends in COPD (Chronic Bronchitis and Emphysema): Morbidity and Mortality Please note, this report is designed for double-sided printing American Lung Association Epidemiology and Statistics Unit Research
More informationMonitoring Healthy People 2010 Arthritis Management Objectives: Education and Clinician Counseling for Weight Loss and Exercise
Monitoring Healthy People 2010 Arthritis Management Objectives: Education and Clinician Counseling for Weight Loss and Exercise Barbara T. Do, MSPH Jennifer M. Hootman, PhD, ATC Charles G. Helmick, MD
More informationTrends in the Incidence of Type 2 Diabetes Mellitus From the 1970s to the 1990s The Framingham Heart Study
Trends in the Incidence of Type 2 Diabetes Mellitus From the 1970s to the 1990s The Framingham Heart Study Caroline S. Fox, MD, MPH; Michael J. Pencina, PhD; James B. Meigs, MD, MPH; Ramachandran S. Vasan,
More informationWhat Are the Effects of Weight Management Pharmacotherapy on Lipid Metabolism and Lipid Levels?
What Are the Effects of Weight Management Pharmacotherapy on Lipid Metabolism and Lipid Levels? Daniel Bessesen, MD Professor of Medicine University of Colorado School of Medicine Chief of Endocrinology,
More informationMental Health: The Role of Public Health and CDC
Mental Health: The Role of Public Health and CDC Ali H. Mokdad, Ph.D. Chief Behavioral Surveillance Branch Division of Adult and Community Health Centers for Disease Control and Prevention Centers for
More informationPhysical Activity Levels Among the General US Adult Population and in Adults With and Without Arthritis
Arthritis & Rheumatism (Arthritis Care & Research) Vol. 49, No. 1, February 15, 2003, pp 129 135 DOI 10.1002/art.10911 2003, American College of Rheumatology SPECIAL ARTICLE Physical Activity Levels Among
More information5. Cardiovascular Disease & Stroke
5. Cardiovascular Disease & Stroke 64: Self-Reported Heart Disease 66: Heart Disease Management 68: Heart Disease Mortality 70: Heart Disease Mortality Across Life Span 72: Stroke Mortality 185: Map 3:
More informationA n aly tical m e t h o d s
a A n aly tical m e t h o d s If I didn t go to the screening at Farmers Market I would not have known about my kidney problems. I am grateful to the whole staff. They were very professional. Thank you.
More informationHealthy Montgomery Obesity Work Group Montgomery County Obesity Profile July 19, 2012
Healthy Montgomery Obesity Work Group Montgomery County Obesity Profile July 19, 2012 Prepared by: Rachel Simpson, BS Colleen Ryan Smith, MPH Ruth Martin, MPH, MBA Hawa Barry, BS Executive Summary Over
More informationKEEP 2009 Summary Figures
S4 29 Summary Figures American Journal of Kidney Diseases, Vol 55, No 3, Suppl 2, 21:pp S4-S57 S41 Definitions DATA ANALYSES DIABETES Self-reported diabetes, self reported diabetic retinopathy, receiving
More informationBody Mass Index Measurement and Obesity Prevalence in Ten U.S. Health Plans
CM&R Rapid Release. Published online ahead of print August 3, 2010 as Original Research Body Mass Index Measurement and Obesity Prevalence in Ten U.S. Health Plans David E. Arterburn, MD, MPH; Gwen L.
More informationAre Smokers Only Using Cigarettes? Exploring Current Polytobacco Use Among an Adult Population
University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Public Health Resources Public Health Resources 2007 Are Smokers Only Using Cigarettes? Exploring Current Polytobacco Use
More informationColorado s Progress toward Year 2000 Objectives
Colorado s Progress toward Year Objectives An update from the Survey Research Unit No. 26 November 1998 Two major roles of Public Health are to reduce preventable death and disability and to enhance quality
More informationThe authors assessed drug susceptibility patterns
Drug Resistance Among Tuberculosis Patients, 1991 and 1992 New York City, CYNTHIA R. DRIVER, RN, MPH THOMAS R. FRIEDEN, MD, MPH ALAN B. BLOCH, MD, MPH IDA M. ONORATO, MD All the authors are with the Division
More informationCHRONIC DISEASE PREVALENCE AMONG ADULTS IN OHIO
OHIO MEDICAID ASSESSMENT SURVEY 2012 Taking the pulse of health in Ohio CHRONIC DISEASE PREVALENCE AMONG ADULTS IN OHIO Amy Ferketich, PhD Ling Wang, MPH The Ohio State University College of Public Health
More informationDepression Screening: An Effective Tool to Reduce Disability and Loss of Productivity
Depression Screening: An Effective Tool to Reduce Disability and Loss of Productivity Kay n Campbell. EdD. RN-C. COHN-S, FAAOHN ICOH Cancun, Mexico March, 2012 What Is It? Common mental disorder Affects
More informationAn Epidemiological Perspective on Type 2 Diabetes Among Adult Men
In Brief Diabetes prevalence, costs, and complications are growing at alarming rates in the United States. The prevalence of diabetes is increasing at similar rates for men and women. Some complications,
More informationPrevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values
Papers in Press. First published June 17, 2004 as doi:10.1373/clinchem.2004.036004 Clinical Chemistry 50:9 000 000 (2004) Lipids, Lipoproteins, and Cardiovascular Risk Factors Prevalence of High C-Reactive
More informationSelf-Reported Influenza-Like Illness and Receipt of Influenza Antiviral Drugs During the 2009 Pandemic, United States,
Self-Reported Influenza-Like Illness and Receipt of Influenza Antiviral Drugs During the 2009 Pandemic, United States, 2009 2010 Matthew Biggerstaff, MPH, Michael Jhung, MD, MPH, Laurie Kamimoto, MD, MPH,
More informationTHE HEALTHY PEOPLE 2000 OBjective
ORIGINAL CONTRIBUTION Changes in Youth Cigarette Use and Intentions Following Implementation of a Tobacco Control rogram Findings From the Florida Youth Tobacco Survey, 1998-2000 Ursula E. Bauer, hd Tammie
More informationOVERWEIGHT AND OBESITY ARE
ORIGINAL CONTRIBUTION The Disease Burden Associated With Overweight and Aviva Must, PhD Jennifer Spadano, MS Eugenie H. Coakley, MA, MPH Alison E. Field, ScD Graham Colditz, MD, DrPH William H. Dietz,
More informationPrevalence And Trends In Obesity Among Aged And Disabled U.S. Medicare Beneficiaries,
Trends Prevalence And Trends In Obesity Among Aged And Disabled U.S. Medicare Beneficiaries, 1997 2002 The rise in obesity among beneficiaries, along with expansions in treatment coverage, could greatly
More informationResearch Article Prevalence and Trends of Adult Obesity in the US,
ISRN Obesity, Article ID 185132, 6 pages http://dx.doi.org/.1155/14/185132 Research Article Prevalence and Trends of Adult Obesity in the US, 1999 12 Ruopeng An CollegeofAppliedHealthSciences,UniversityofIllinoisatUrbana-Champaign,GeorgeHuffHallRoom13,16South4thStreet,
More informationPhysical Activity and Nutrition in Minnesota
DATA BRIEF Physical Activity and Nutrition in Minnesota Physical activity and fruit and vegetable consumption are key behaviors that influence a person s weight. Two important components of obesity prevention
More informationWhy Do We Care About Prediabetes?
Why Do We Care About Prediabetes? Complications of Diabetes Diabetic Retinopathy Leading cause of blindness in adults 1,2 Diabetic Nephropathy Leading cause of Kidney failure Stroke 2- to 4-fold increase
More informationAdult Immunizations & the Workplace
Adult Immunizations & the Workplace Samuel B. Graitcer, MD Office of Associate Director for Adult Immunizations Immunization Services Division National Center for Immunization & Respiratory Diseases Immunization
More informationAge and the Burden of Death Attributable to Diabetes in the United States
American Journal of Epidemiology Copyright 2002 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 156, No. 8 Printed in U.S.A. DOI: 10.1093/aje/kwf111 Age and the Burden of
More informationThe clinical and economic benefits of better treatment of adult Medicaid beneficiaries with diabetes
The clinical and economic benefits of better treatment of adult Medicaid beneficiaries with diabetes September, 2017 White paper Life Sciences IHS Markit Introduction Diabetes is one of the most prevalent
More informationCalories Consumed From Alcoholic Beverages by U.S. Adults,
NCHS Data Brief No. November Calories Consumed From Alcoholic Beverages by U.S. Adults, 7 Samara Joy Nielsen, Ph.D., M.Div.; Brian K. Kit, M.D., M.P.H.; Tala Fakhouri, Ph.D., M.P.H.; and Cynthia L. Ogden,
More informationMichael S. Blaiss, MD
Michael S. Blaiss, MD Clinical Professor of Pediatrics and Medicine Division of Clinical Immunology and Allergy University of Tennessee Health Science Center Memphis, Tennessee Speaker s Bureau: AstraZeneca,
More informationHIGH BLOOD PRESSURE IS AN EStablished
ORIGINAL CONTRIBUTION Trends in Blood Pressure Among Children and Adolescents Paul Muntner, PhD Jiang He, MD, PhD Jeffrey A. Cutler, MD Rachel P. Wildman, PhD Paul K. Whelton, MD, MSc HIGH BLOOD PRESSURE
More information